Association between Pulmonary Fibrosis and Coronary Artery Disease

Archives of Internal Medicine

Volumn 164, Issue 5, 2004, Pages 551-556

  Kizer, Jorge R ^a   Zisman, David A ^b,c   Blumenthal, Nancy P ^b   Kotloff, Robert M ^b   Kimmel, Stephen E ^b   Strieter, Robert M ^c   Arcasoy, Selim M ^d   Ferrari, Victor A ^b   Hansen Flaschen, John ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Columbia Univ Coll Phys/Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROSIS; CLINICAL RESEARCH; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; HUMAN; LUNG FIBROSIS; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PATIENT REFERRAL; PRIORITY JOURNAL; RISK FACTOR; UNIVERSITY HOSPITAL;

ADULT; CAUSALITY; COHORT STUDIES; COMORBIDITY; CONFOUNDING FACTORS (EPIDEMIOLOGY); CORONARY ARTERIOSCLEROSIS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; ODDS RATIO; PREVALENCE; PULMONARY FIBROSIS; RISK FACTORS; SMOKING;

EID: 1542287300     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.164.5.551     Document Type: Article

References (35)

1. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999;340: 115-126.
2. Chan ED, Worthen GS, Augustin A, Lapadat R, Riches DWH. Inflammation in the pathogenesis of interstitial lung disease. In: Schwartz MI, King TE, eds. Interstitial Lung Disease. 3rd ed. Hamilton, Ontario: BC Decker Inc; 1998:135-164.
3. Strieter RM, Keane MP, Standiford TJ, Kunkel SL. Cytokine biology and the pathogenesis of interstitial lung disease. In: Schwartz MI, King TE, eds. Interstitial Lung Disease. 3rd ed. Hamilton, Ontario: BC Decker Inc; 1998:181-205.
4. Yamanouchi H, Fujita J, Yoshinouchi T, et al. Measurement of hepatocyte growth factor in serum and bronchoalveolar lavage fluid in patients with pulmonary fibrosis. Respir Med. 1998;92:273-278.
5. Ziegenhagen MW, Zabel P, Zissel G, Schlaak M, Muller-Quernheim J. Serum level of interleukin-8 is elevated in idiopathic pulmonary fibrosis and indicates disease activity. Am J Respir Crit Care Med. 1998;157:762-768.
6. Yokoyama T, Kanda T, Kobayashi I, Suzuki T. Serum levels of interleukin-8 as a marker of disease activity in patients with chronic sarcoidosis. J Med. 1995;26:209-219.
7. Drent M, Wirnsberger RM, de Vries J, van Dieijen-Visser MP, Wouters EFM, Schols AMWJ. Association of fatigue with an acute phase response in sarcoidosis. Eur Respir J. 1999;13:718-722.
8. Schwartz MI. Approach to the understanding, diagnosis, and management of interstitial lung disease. In: Schwartz MI, King TE, eds. Interstitial Lung Disease. 3rd ed. Hamilton, Ontario: BC Decker Inc; 1998:3-30.
9. American Thoracic Society, European Respiratory Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. Am J Respir Crit Care Med. 2000;161: 646-664.
10. Sholter DE, Armstrong PW, Adverse effects of corticosteroids on the cardiovascular system. Can J Cardiol. 2000;16:505-511.
11. Jousilahti P, Vartianinen E, Tuomilehto J, Puska P. Symptoms of chronic bronchitis and the risk of coronary disease. Lancet. 1996;348:567-572.
12. Wedzicha JA, Seemungal TAR, MacCallum PK, et al. Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels. Thromb Haemost. 2000;84:210-215.
13. Muhlenstein JB. Chronic infection and coronary artery disease. Med Clin North Am. 2000;84:123-148.
14. American Thoracic Society, European Respiratory Society, World Association of Sarcoidosis and Other Granulomatous Disorders. Statement on sarcoidosis. Am J Respir Crit Care Med. 1999;160:736-755.
15. Uyemura K, Demer LL, Castle SC, et al. Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis. J Clin Invest. 1996;97:2130-2138.
16. Frostegard J, Ulfgren AK, Nyberg P, et al. Cytokine expression in advanced human atherosclerotic plaques. Atherosclerosis. 1999;145:33-43.
17. De Boer OJ, Van Der Wal AC, Verhagen CE, Becker AE. Cytokine secretion profiles of cloned T cells from human aortic atherosclerotic plaques. J Pathol. 1999;188: 174-179.
18. Montuschi P, Ciabattoni G, Paredi P, et al. 8-Isoprostane as a biomarker of oxidative stress in interstitial lung diseases. Am J Respir Crit Care Med. 1998;158: 1524-1527.
19. Turner-Warwick M. Systemic arterial patterns in the lung and clubbing of the fingers. Thorax. 1963;18:238-250.
20. Barks JL, McQuillan JJ, Iademarco MF. TNF-α and ILF-4 synergistically increase vascular cell adhesion molecule-1 expression in cultured vascular smooth muscle cells. J Immunol. 1997;159:4532-4538.
21. Iademarco MF, Barks JK, Dean DC. Regulation of vascular cell adhesion molecule-1 expression by IL-4 and TNF-α in cultured endothelial cells. J Clin Invest. 1995;95:264-271.
22. Khew-Goodall Y, Wadham C, Stein BN, Gamble JR, Vadas MA. Stat6 activation is essential for interleukin-4 induction of P-selectin transcription in human umbilical vein endothelial cells. Arterioscler Thromb Vasc Biol. 1999;19:1421-1429.
23. Natarajan R, Rosdahl J, Gonzales N, Bai W. Regulation of 12-lipoxygenase by cytokines in vascular smooth muscle cells. Hypertension. 1997;30:873-879.
24. Folcik VA, Aamir R, Cathcart MK. Cytokine modulation of LDL oxidation by activated human monocytes. Arterioscler Thromb Vasc Biol. 1997;17:1954-1961.
25. Girard N, Maingonnat C, Bertrand P, Vasse M, Delpech B. Hyaluronectin secretion by monocytes. Cytokine. 1999;11:579-584.
26. Trochon V, Mabilat-Pragnon C, Bertrand P, et al. Hyaluronectin blocks the stimulatory effect of hyaluronan-derived fragments on endothelial cells during angiogenesis in vitro. FEBS Lett. 1997;418:6-10.
27. Moulton KS, Heller E, Konerding MA, Flynn E, Palinski W, Folkman J. Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Circulation. 1999;99:1726-1732.
28. Simonini A, Moscucci M, Muller DWM, et al. IL-8 is an angiogenic factor in human coronary atherectomy tissue. Circulation. 2000;101:1519-1526.
29. Dickinson CJ. Lung diseases associated with digital clubbing. Clin Exp Rheumatol. 1992;10(suppl 7):23-25.
30. Bigler FC. The morphology of clubbing. Am J Pathol. 1958;34:237-261.
31. Hirakata Y, Kitamura S. Elevated serum transforming growth factor al level in primary lung cancer patients with finger clubbing. Eur J Clin Invest. 1996;26:820-823.
32. Tisi GM, Conrique A, Barrett-Connor E, Grundy SM. Increased high density lipoprotein cholesterol in obstructive pulmonary disease (predominant emphysematous type). Metabolism. 1981;30:340-346.
33. Bolton CH, Mulloy E, Harvey J, Downs LG, Hartog M. Plasma and lipoprotein lipids and apolipoproteins AI, AII and B in patients with chronic airflow limitation. J R Soc Med. 1989;82:91-92.
34. Fekette T, Mosler R. Plasma lipoproteins in chronic obstructive pulmonary disease. Horm Metab Res. 1987;19:661-662.
35. Basili S, Ferroni P, Vieri M, et al. Lipoprotein(a) serum levels in patients affected by chronic obstructive pulmonary disease. Atherosclerosis. 1999;147:249-252.